Hypothesis
Age‑related decline of Lactonifactor longoviformis reduces equol production from dietary daidzein, diminishing ERβ‑mediated anti‑inflammatory signaling and accelerating inflammaging.
Mechanistic rationale
While L. longoviformis is known for lignan dehydrogenation, its genome harbors flavin‑dependent reductase domains homologous to those in validated equol‑producing strains (e.g., Slackia isoflavoniconvertens). Age‑associated shifts in bile acid pools—particularly increased secondary bile acids such as deoxycholic acid—have been shown to suppress Clostridiaceae metabolic activity Bile acid inhibition. We hypothesize that these bile acid changes selectively inhibit the cryptic daidzein‑reducing pathway in L. longoviformis, lowering equol synthesis in older hosts.
Equol acts as a selective estrogen receptor β (ERβ) agonist, dampening NF‑κB driven cytokine production ERβ anti‑inflammatory. Reduced equol therefore removes a microbial checkpoint on intestinal and systemic inflammation, contributing to the well‑documented decline in tryptophan‑indole metabolism Tryptophan decline and the rise of inflammaging observed after age 34‑54.
Testable predictions
- Abundance correlation – Quantitative PCR targeting the L. longoviformis 16S rRNA gene will show a significant negative correlation with host age (r < ‑0.4, p < 0.01) across cohorts aged 20‑80.
- **





























